Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile

Annals of Clinical Biochemistry

Volumn 33, Issue 6, 1996, Pages 540-544

  Jefferson, A ^a   Reynolds, T M ^a   Elves, A ^b   Wierzbicki, A S ^c  

^a DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Immunoblotting; Renal calculi; Sialoprotein; Uromodulin

Indexed keywords

TAMM HORSFALL GLYCOPROTEIN;

ADULT; ARTICLE; CALCIUM STONE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOBLOTTING; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; STONE FORMATION; URINALYSIS;

EID: 0029907222     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300609     Document Type: Article

References (16)

1. Tamm I, Horsfall F. Characterisation and separation of an inhibitor of viral haemagglutination present in urine. Proc Soc Expl Biol Med 1950; 74: 109-14
2. Kumar S, Muchmore A. Tamm-Horsfall protein - uromodulin (1950-1990). Kidney Int 1990; 37: 1395-401
3. Fletcher A, Neuberger A, Ratcliffe W. Tamm-Horsfall urinary glycoprotein: the chemical composition. Biochem J 1970; 120: 417-24
4. Ronco P, Brunisholz M, Legendre M, Chatelet F, Verroust P, Richet G. Physiopathologic aspects of Tamm-Horsfall protein: A phylogenetically conserved marker of the thick ascending limb of Henle's loop. Adv Nephrol 1987; 16: 231-50
5. Hess B, Nakagawa Y, Coe F. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 1989; 257: F99-F106
6. Yoshioka T, Koide T, Utsunomiya M, Itatani H, Oka T, Sonoda T. Possible role of Tamm-Horsfall glycoprotein in calcium oxalate crystallisation. Br J Urol 1989; 64: 463-7
7. Ryall R, Hargnett R, Hibberd C, Edyvane K, Marshall V. Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol Res 1991; 19: 181-8
8. Coe F, Nakagawa Y, Parks J. Inhibitors within the nephron. Am J Kidney Dis 1991; 17: 407-13
9. Hess B. The role of Tamm-Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallisation processes. Scanning Microsc 1991; 5: 689-96
10. Knörle R, Schnierle P, Koch A, Buchholz N-P, Hering F, Seiler H, et al. Tamm-Horsfall glycoprotein: Role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy. Clin Chem 1994; 40: 1739-43
11. Hess B, Nakagawa Y, Parks J, Coe F. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 1991; 260: F569-78
12. Keir G, Zeman A, Brookes G, Porter M, Thompson E. Immunoblotting of transferrin in the identification of carebrospinal fluid otorrhoea and rhinorrhoea. Ann Clin Biochem 1992; 29: 210-3
13. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37: 2029-37
14. Stevenson FK, Cleave AJ, Kent PW. The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm Horsfall glycoprotein. Biochem Biophys Acta 1971; 236: 59-66
15. Hess B, Zipperle L, Jaeger P. Citrate and calcium effects on Tamm Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 1993; 265: F784-91
16. Boyce W, Swanson M. Biocolloids of urine in health and in calculous disease. II. Electrophoretic and biochemical studies of a mucoprotein insoluble in molar sodium chloride. J Clin Invest 1995; 34: 1581-9